相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NAADP Signaling: New Kids on the Block
Andreas H. Guse
CELLS (2022)
2-Methoxyestradiol and its derivatives inhibit store-operated Ca2+ entry in T cells: Identification of a new and potent inhibitor
Anke Loehndorf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)
Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?
Abdullah Al Shoyaib et al.
PHARMACEUTICAL RESEARCH (2020)
Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure
Wolfgang Dohle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects
Barry V. L. Potter
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health
Mark P. Thomas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential
Mark P. Thomas et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives
Hans-Peter Hartung et al.
CURRENT OPINION IN NEUROLOGY (2014)
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation
Gordon S. Duncan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Role of 2-methoxyestradiol as inhibitor of arthritis and osteoporosis in a model of postmenopausal rheumatoid arthritis
Alexandra Stubelius et al.
CLINICAL IMMUNOLOGY (2011)
Structures of Human Carbonic Anhydrase II/Inhibitor Complexes Reveal a Second Binding Site for Steroidal and Nonsteroidal Inhibitors
Gyles E. Cozier et al.
BIOCHEMISTRY (2010)
Nicotinic acid adenine dinucleotide phosphate-mediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system
Chiara Cordiglieri et al.
BRAIN (2010)
Therapeutic Promises of 2-Methoxyestradiol and Its Drug Disposition Challenges
Svetlana Verenich et al.
MOLECULAR PHARMACEUTICS (2010)
Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies
Amye J. Tevaarwerk et al.
CLINICAL CANCER RESEARCH (2009)
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions
Ingo Bartholomaeus et al.
NATURE (2009)
STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells
Simon P. Newman et al.
CLINICAL CANCER RESEARCH (2008)
The therapeutic potential of a series of orally bioavailable antiangiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers
S. P. Newman et al.
BRITISH JOURNAL OF CANCER (2007)
2-methoxyestradiol - a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents
Tara E. Sutherland et al.
DRUG DISCOVERY TODAY (2007)
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol
S. K. Chander et al.
BRITISH JOURNAL OF CANCER (2007)
Instant effect of soluble antigen on effector T cells in peripheral immune organs during immunotherapy of autoimmune encephalomyelitis
Francesca Odoardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Calcium signalling in lymphocyte activation and disease
Stefan Feske
NATURE REVIEWS IMMUNOLOGY (2007)
2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: Synthesis, in vitro SAR, protein crystallography, and in vivo activity
Mathew P. Leese et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai
Andriy V. Yeromin et al.
NATURE (2006)
Amplification of CRAC current by STIM1 and CRACM1 (Orai1)
Christine Peinelt et al.
NATURE CELL BIOLOGY (2006)
Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain
Burkhard Becher et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry
M. Vig et al.
SCIENCE (2006)
Phase I study of STX 64 (667 Coumate) in breast cancer patients: The first study of a steroid sulfatase inhibitor
SJ Stanway et al.
CLINICAL CANCER RESEARCH (2006)
The role of 17 beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells
SP Newman et al.
CANCER RESEARCH (2006)
Steroid sulfatase: Molecular biology, regulation, and inhibition
MJ Reed et al.
ENDOCRINE REVIEWS (2005)
Crystal structure of human carbonic anhydrase II at 1.95 Å resolution in complex with 667-cournate, a novel anti-cancer agent
MD Lloyd et al.
BIOCHEMICAL JOURNAL (2005)
Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents
CR Ireson et al.
BRITISH JOURNAL OF CANCER (2004)
The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis
N Kawakami et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats
CR Ireson et al.
BRITISH JOURNAL OF CANCER (2004)
Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates
YT Ho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis
A Flügel et al.
IMMUNITY (2001)
Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates
LWL Woo et al.
CHEMISTRY & BIOLOGY (2000)
分享论文
